Pere Gascón
Instituto de Investigación de Enfermedades Raras(ES)
Publications by Year
Research Areas
Erythropoietin and Anemia Treatment, Neutropenia and Cancer Infections, Biosimilars and Bioanalytical Methods, Cancer Cells and Metastasis, Iron Metabolism and Disorders
Most-Cited Works
- → Ipilimumab plus Dacarbazine for Previously Untreated Metastatic Melanoma(2011)4,451 cited
- → The European Cancer Anaemia Survey (ECAS): A large, multinational, prospective survey defining the prevalence, incidence, and treatment of anaemia in cancer patients(2004)917 cited
- → A randomized double-blind multicenter phase III study offixed-dose single-administration pegfilgrastim versus daily filgrastim in patients receiving myelosuppressive chemotherapy(2002)582 cited
- → Phase II Multicenter Study of the Antiepidermal Growth Factor Receptor Monoclonal Antibody Cetuximab in Combination With Platinum-Based Chemotherapy in Patients With Platinum-Refractory Metastatic and/or Recurrent Squamous Cell Carcinoma of the Head and Neck(2005)491 cited
- → Phase II and Tumor Pharmacodynamic Study of Gefitinib in Patients with Advanced Breast Cancer(2005)408 cited
- → Randomized Active-Controlled Phase II Study of Denosumab Efficacy and Safety in Patients With Breast Cancer-Related Bone Metastases(2007)383 cited